have shown that the regulation of G Protein-Coupled Receptors (GPCRs) by new
drugs can be simpler than generally thought — it can be mediated by engaging
only the end of the receptor, which is called the tail of the receptor.
Significance of these findings:
With this, discovering new drugs that bind to G Protein-Coupled
Receptors (GPCRs), which are central to almost every physiological process in
our body such as vision, taste, immune response and cardiovascular regulation,